Loading...
*  DNA vaccination
Currently no DNA vaccines have been approved for human use. Research is investigating the approach for viral, bacterial and ... Second generation vaccines were developed to reduce the risks from live vaccines. These are subunit vaccines, consisting of ... First generation vaccines are whole-organism vaccines - either live and weakened, or killed forms. Live, attenuated vaccines, ... but limit viral infection by down-regulating the expression of viral components. DNA vaccinations can be used to curb viral ...
*  HIV vaccine
Researchers hypothesized that vaccines designed to maintain activated effector memory T cells might impair viral replication at ... Vaccine Research Center (VRC)- Information concerning Preventive HIV vaccine research studies NIAID HIV vaccine site (DAIDS) ... Global Alliance for Vaccines and Immunization (GAVI) International AIDS Vaccine Initiative (IAVI) AIDS Vaccine Advocacy ... Adenovirus vectors and many other viral vectors currently used in HIV vaccines, will induce a rapid memory immune response ...
*  Malaria vaccine
The viral vectored vaccine, targeting a full-length P. falciparum reticulocyte-binding protein homologue 5 (PfRH5) was found to ... Malaria vaccine is a vaccine that is used to prevent malaria. The only approved vaccine as of 2015 is RTS,S. It requires four ... The vaccine was shown to be less effective for infants. Three doses of vaccine plus a booster reduced the risk of clinical ... The Type 2 vaccine could be thought of as a 'travellers' vaccine', aiming to prevent all cases of clinical symptoms in ...
*  Glen Dettman
Kalokerinos A, Dettman G (1980). "Viral vaccines vital or vulnerable". Australasian Nurses J. 9 (9): 27-32. PMID 6904225. ... Kalokerinos A, Dettman G (1981). "Mumps" the word but you have yet another vaccine deficiency". Australasian Nurses J. 10 (6): ... Kalokerinos A, Dettman G (1978). "Vaccines: "who" benefits?". Australasian Nurses J. 7 (11): 15-6. PMID 100089. Kalokerinos A, ... which yielded a modified staphylococcal vaccine. In 1950, Dettman founded the Oakleigh Pathology Service and was later elected ...
*  Alice Miles Woodruff
Carmichael, L.E. (2 December 1991). Viral Vaccines Produced in Embryonating Eggs. Quality control of veterinary vaccines in ...
*  Sudhanshu Vrati
Kaushik, Bharati,; Sudhanshu, Vrati,. "Viral Vaccines in India: An Overview". Proceedings of the National Academy of Sciences, ... Later, he concentrated on the development of DNA vaccines and the details of the work has since been published as an article, ... Known for his studies in the fields of RNA virus replication and vaccine development, Vrati is an elected fellow of the ... List of vaccine topics Immunotherapy India portal Medicine portal Please see Selected bibliography section "Awardees of ...
*  Vaccination and religion
The cell culture media of some viral vaccines, and the virus of the rubella vaccine, are derived from tissues taken from ... "Moral considerations with certain viral vaccines" (PDF). Christ Pharm. 2 (2): 3-6. ISSN 1094-9534. Retrieved 2009-05-11. [dead ... School, 186 F. Supp.2d 187 (N.D.N.Y. 2002) "Pinkbook - HPV - Epidemiology of Vaccine Preventable Diseases - CDC". www.cdc.gov. ... Saying that data suggests "that African American males who received the MMR vaccine before age 36 months were at increased risk ...
*  WI-38
Fletcher, MA; Hessel, L; Plotkin, SA (1998). "Human diploid cell strains (HDCS) viral vaccines". Developments in biological ... Over a billion vaccine doses worldwide can be traced to work done on WI-38, covering conditions including measles and rubella. ... Fetal tissue in vaccines "WI-38 (ATCC® CCL-75™)". Hayflick, Leonard (March 1965). "The Limited in vitro Lifetime of Human ... Researchers in labs across the globe have since used WI-38 in their discoveries, most notably in the development of vaccines. ...
*  Equine viral arteritis
Minke, JM; Audonnet, JC; Fischer, L (2004). "Equine viral vaccines: the past, present and future". Veterinary research. 35 (4 ... Equine viral arteritis (EVA) is a disease of horses caused by equine arteritis virus, an RNA virus of the genus Arterivirus. ... A vaccine is available in the UK and Europe, however in laboratory tests it is not possible to distinguish between antibodies ... Blood samples, nasal swabs and semen can be used for isolation of the virus, detection of the viral RNA by polymerase chain ...
*  MMR vaccine
... pathogenesis and significance of autoimmune manifestations after viral vaccines". Vaccine. 23 (30): 3876-86. doi:10.1016/j. ... The MMR vaccine (also known as the MPR vaccine after the Latin names of the diseases) is an immunization vaccine against ... vaccine, has been proposed as a replacement for the MMR vaccine to simplify administration of the vaccines. Preliminary data ... Vaccine. 30 (48): 6731-3. doi:10.1016/j.vaccine.2012.08.075. PMID 22975026. Vaccine Information Statement from the U.S. Center ...
*  Peter Palese
He has been awarded multiple patents on viral vaccines and antivirals. Palese received his Ph.D. in chemistry in 1969 and his M ... Reverse genetics also assist in the development of new flu vaccines. Palese is the author of multiple book chapters and more ... Palese built "the first genetic maps for influenza A, B and C viruses, identified the function of several viral genes, ... ... Zamarin, D.; Ortigoza, M. B.; Palese, P. (2006). "Influenza a Virus PB1-F2 Protein Contributes to Viral Pathogenesis in Mice". ...
*  Recombinant virus
This may be used to produce viral vaccines or gene therapy vectors. It is also used to refer to naturally occurring ... Jeffery Taubenberger on: A Recombinant Virus Viral Genetics Transmission of Influenza A Viruses Between Animals and People. ...
*  Chlorocebus
... moving towards cell culture-based viral vaccines". Expert review of vaccines. 8 (5): 607-618. doi:10.1586/erv.09.19. PMID ... Accessed 2008-07-11 Barrett, P.N.; Mundt, W.; Kristner, O.; Howard, M.K. (2009). "Vero cell platform in vaccine production: ... and cell lines derived from its tissues are still used today to produce vaccines for polio and smallpox. Chlorocebus species ...
*  Newcastle disease
An inactivated viral vaccine is available, as well as various combination vaccines. A thermotolerant vaccine is available for ... FAO Manual on Vaccines Csatary, LK; Moss, RW; Beuth, J; Töröcsik, B; Szeberenyi, J; Bakacs, T (Jan-Feb 1999). "Beneficial ... In 2011, Memorial Sloan-Kettering Cancer Center researchers found that NDV modified with the viral protein NS1 had a higher ... Vigil, A; Martinez, O; Chua, MA; García-Sastre, A (Nov 2008). "Recombinant Newcastle disease virus as a vaccine vector for ...
*  Pigeon pox
... is a viral disease to which pigeons are susceptible. There is a live viral vaccine available (ATCvet code: QI01ED01 ...
*  Timeline of biotechnology
1798 - Edward Jenner uses first viral vaccine to inoculate a child from smallpox. 1802 - The first recorded use of the word ... 2009 - Cedars-Sinai Heart Institute uses modified SAN heart genes to create the first viral pacemaker in guinea pigs, now known ... 1885 - Louis Pasteur and Emile Roux develop the first rabies vaccine and use it on Joseph Meister. 20th century'' 1919 - Károly ... 1881 - Louis Pasteur develops vaccines against bacteria that cause cholera and anthrax in chickens. ...
*  MMR vaccine controversy
... pathogenesis and significance of autoimmune manifestations after viral vaccines". Vaccine. 23 (30): 3876-86. doi:10.1016/j. ... With no such risk seen in vaccines using the Jeryl Lynn mumps strain, the UK NHS withdrew two of the three MMR vaccines then ... By 2003 it was still trying to find a combined vaccine to replace MMR. It was later discovered that some of the vaccines were ... "comments on MMR vaccine". FOIA Centre. Retrieved 2011-01-08. "Families win lawsuit over MMR vaccine". The Japan Times. 14 March ...
*  Maharaj Kishan Bhan
He is known for developing Rota Viral Vaccine in collaboration with Bharat Biotech International. He was positioned as ...
*  Molecular virology
Viral vaccines contain inactivated viruses which have lost their ability to replicate. These vaccines can prevent or lower the ... The capsid could have been degraded by either host or viral enzymes, releasing the viral genome into the cell. Replication is ... Uncoating is the removal of viral capsid, which makes the viral nucleic acids available for transcription. ... transcribes into a positive-sense RNA via a viral polymerase, and translates into viral protein.The viruses in this class ...
*  Egg allergy
"Recommendations for administering the triple viral vaccine and anti-influenza vaccine in patients with egg allergy". Allergol ... which could be egg protein or the gelatin or the neomycin components of the vaccine) should not receive a flu vaccine. Each ... Each year, vaccines are created to provide protection against the flu viruses expected to be prevalent in the upcoming cold ... Influenza vaccines are created by injecting a live virus into fertilized chicken eggs. The viruses are harvested, killed and ...
*  Michael A. Epstein
"Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine". Clinical and experimental ... Epstein, M. A.; Randle, B. J.; Finerty, S.; Kirkwood, J. K. (1986). "Not all potently neutralizing, vaccine-induced antibodies ... "Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs". Journal of Virology. 35 (3): 603- ... Epstein changed his research focus from cancer causing viruses in chickens to searching for a viral origin of Burkitt's ...
*  Cell culture
Mass culture of animal cell lines is fundamental to the manufacture of viral vaccines and other products of biotechnology. ... Depending on the species of the virus, infection and viral replication may result in host cell lysis and formation of a viral ... Viral culture is also related, with cells as hosts for the viruses. The laboratory technique of maintaining live cell lines (a ... The injectable polio vaccine developed by Jonas Salk was one of the first products mass-produced using cell culture techniques ...
*  MRC-5
"The Status of Human Diploid Cell Strain MRC-5 as an Approved Substrate for the Production of Viral Vaccines". Journal of ... MRC-5 cells are used to produce several vaccines including MMR, Varicella and Polio. Infected MRC-5 cells secrete the virus, ...
*  Ann C. Palmenberg
This technique provides the potential for the creation of viral vaccines by inoculating the viral vector into a host cell, ... This type of research works toward finding a viral vaccines for constantly changing viruses, such as rhinovirus and HIV. In ... This can be used for an increase in proteins made from an IRES, while stopping the production of proteins that are not viral ... Method of Inhibiting Picornavirus Disease is a technique involving the use of a vaccine in order to stimulate the immune system ...
*  Tumor antigen vaccine
Tumor antigen vaccines work the same way that viral vaccines work, by training the immune system to attack cells that contain ... Viral vaccines usually work by preventing the spread of the virus. Similarly, cancer vaccines can be designed to target common ... The difference is that the antigens for viral vaccines are derived from viruses or cells infected with virus, while the ... Cancer vaccines can be cell-based, protein- or peptide-based, or gene-based (DNA/RNA). Cell-based vaccines include tumor cells ...
*  Camelpox
The DNA is encased in the viral core. Two lateral bodies are found outside the viral core, and are believed to hold the enzymes ... An inactivated vaccine is also available, but must be administered yearly to maintain protection. The Camelpox virus is ... The most common medication used to treat Camelpox is Cidofovir, a broad spectrum anti-viral that acts by inhibiting the viral ... Eventually, the viral core dissolves, and the genetic material is bare within the cytoplasm. When all of the structural ...
*  Ataxia-telangiectasia
If antibody function is normal, all routine childhood immunizations including live viral vaccines (measles, mumps, rubella and ... Such individuals develop complications from live viral vaccines (measles, mumps, rubella and chickenpox), chronic or severe ... the 23-valent pneumococcal vaccine should be administered. Immunization with the 23-valent pneumococcal vaccine should be ... If the vaccines do not work and the patient continues to have problems with infections, gamma globulin therapy (IV or ...